Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Strong results and positive outlook enable upward target revision INFLOWS NETOPERATINGRESULT OPERATIONAL CAPITALGENERATION EXPECTED 2025 CASH UPSTREAM EUR 10.5 billion ...
-
IDEX Biometrics ASA's first half 2025 report is attached to this notice. Recent highlights: Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted...
-
MELBOURNE, Australia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) advises it has entered into a partnership with InvestorHub, a direct-to-investor engagement software...
-
LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock...
-
FT. LAUDERDALE, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- CSLM Digital Asset Acquisition Corp III, Ltd (the “Company”), a newly organized special purpose acquisition company formed as a Cayman...
-
MINNEAPOLIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative,...
-
All amounts are in United States dollars, unless otherwise stated. TORONTO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Alamos Gold Inc. (TSX:AGI; NYSE:AGI) (“Alamos” or the “Company”) has released its 2024...
-
TAMPA, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that on August 20,...
-
Immuneering Announces Closing of $25 Million Private Placement
-
BRISBANE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative...